Navigation

FDA, EU diverge on AstraZeneca COVID-19 vaccine

FDA, EU diverge on AstraZeneca COVID-19 vaccine
The FDA has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists

Share

Post A Comment:

0 comments:

Leave a comment. Thanks!